Promising activity of selinexor in the treatment of a patient with refractory diffuse large B-cell lymphoma and central nervous system involvement

被引:24
作者
Bobillo, Sabela [1 ,2 ]
Abrisqueta, Pau [1 ,2 ]
Carpio, Cecilia [1 ,2 ]
Raheja, Priyanka [1 ,2 ]
Castellvi, Josep [3 ]
Crespo, Marta [4 ]
Bosch, Francesc [1 ,2 ,4 ]
机构
[1] Univ Hosp Vall dHebron, Dept Hematol, Barcelona, Spain
[2] Univ Hosp Vall dHebron, Vall dHebron Inst Oncol VHIO, Barcelona, Spain
[3] Univ Hosp Vall dHebron, Dept Pathol, Barcelona, Spain
[4] Vall dHebron Inst Oncol VHIO, Lab Expt Hematol, Barcelona, Spain
关键词
NUCLEAR EXPORT; INHIBITION;
D O I
10.3324/haematol.2017.181636
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E92 / E93
页数:2
相关论文
共 14 条
[11]  
Lassen UN, 2016, J CLIN ONCOL S, V34
[12]   First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid Tumors [J].
Razak, Albiruni R. Abdul ;
Mau-Soerensen, Morten ;
Gabrail, Nashat Y. ;
Gerecitano, John F. ;
Shields, Anthony F. ;
Unger, Thaddeus J. ;
Saint-Martin, Jean R. ;
Carlson, Robert ;
Landesman, Yosef ;
McCauley, Dilara ;
Rashal, Tami ;
Lassen, Ulrik ;
Kim, Richard ;
Stayner, Lee-Anne ;
Mirza, Mansoor R. ;
Kauffman, Michael ;
Shacham, Sharon ;
Mahipal, Amit .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (34) :4142-+
[13]   How I treat CNS lymphomas [J].
Rubenstein, James L. ;
Gupta, Neel K. ;
Mannis, Gabriel N. ;
LaMarre, Amanda K. ;
Treseler, Patrick .
BLOOD, 2013, 122 (14) :2318-2330
[14]   CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications [J].
Tai, Y-T ;
Landesman, Y. ;
Acharya, C. ;
Calle, Y. ;
Zhong, M. Y. ;
Cea, M. ;
Tannenbaum, D. ;
Cagnetta, A. ;
Reagan, M. ;
Munshi, A. A. ;
Senapedis, W. ;
Saint-Martin, J-R ;
Kashyap, T. ;
Shacham, S. ;
Kauffman, M. ;
Gu, Y. ;
Ghobrial, I. ;
Zhan, F. ;
Kung, A. L. ;
Schey, S. A. ;
Richardson, P. ;
Munshi, N. C. ;
Anderson, K. C. .
LEUKEMIA, 2014, 28 (01) :155-165